Provider: NIHR Journals Library
Content:text/plain; charset="UTF-8"
TY  - JOUR
LB  - 1.
AU  - Kolias, AG
AU  - Chari, A
AU  - Santarius, T
AU  - Hutchinson, PJ
TI  -  Chronic subdural haematoma: modern management and emerging therapies
J2  - Nat Rev Neurol
SP  - 570
PY  - 2014
VL  - 10
SP  - 570
ER  - 
TY  - JOUR
LB  - 2.
AU  - Kolias, AG
AU  - Edlmann, E
AU  - Thelin, EP
AU  - Bulters, D
AU  - Holton, P
AU  - Suttner, N
TI  -  Correction to: dexamethasone for adult patients with a symptomatic chronic subdural haematoma (Dex-CSDH) trial: study protocol for a randomised controlled trial
J2  - Trials
SP  - 1
PY  - 2019
VL  - 20
SP  - 1
ER  - 
TY  - JOUR
LB  - 3.
AU  - Hutchinson, PJ
AU  - Edlmann, E
AU  - Bulters, D
AU  - Zolnourian, A
AU  - Holton, P
AU  - Suttner, N
TI  -  Trial of dexamethasone for chronic subdural hematoma
J2  - N Engl J Med
SP  - 2616
PY  - 2020
VL  - 383
SP  - 2616
ER  - 
TY  - JOUR
LB  - 4.
AU  - Ducruet, AF
AU  - Grobelny, BT
AU  - Zacharia, BE
AU  - Hickman, ZL
AU  - DeRosa, PL
AU  - Andersen, KN
TI  -  The surgical management of chronic subdural hematoma
J2  - Neurosurg Rev
SP  - 155
PY  - 2012
VL  - 35
SP  - 155
ER  - 
TY  - JOUR
LB  - 5.
AU  - Beard, JR
AU  - Officer, A
AU  - de Carvalho, IA
AU  - Sadana, R
AU  - Pot, AM
AU  - Michel, JP
TI  -  The World report on ageing and health: a policy framework for healthy ageing
J2  - Lancet
SP  - 2145
PY  - 2016
VL  - 387
SP  - 2145
ER  - 
TY  - JOUR
LB  - 6.
AU  - Balser, D
AU  - Farooq, S
AU  - Mehmood, T
AU  - Reyes, M
AU  - Samadani, U
TI  -  Actual and projected incidence rates for chronic subdural hematomas in United States Veterans Administration and civilian populations
J2  - J Neurosurg
SP  - 1209
PY  - 2015
VL  - 123
SP  - 1209
ER  - 
TY  - JOUR
LB  - 7.
AU  - Santarius, T
AU  - Kirkpatrick, PJ
AU  - Ganesan, D
AU  - Chia, HL
AU  - Jalloh, I
AU  - Smielewski, P
TI  -  Use of drains versus no drains after burr-hole evacuation of chronic subdural haematoma: a randomised controlled trial
J2  - Lancet
SP  - 1067
PY  - 2009
VL  - 374
SP  - 1067
ER  - 
TY  - JOUR
LB  - 8.
AU  - Brennan, PM
AU  - Kolias, AG
AU  - Joannides, AJ
AU  - Shapey, J
AU  - Marcus, HJ
AU  - Gregson, BA
TI  -  The management and outcome for patients with chronic subdural hematoma: a prospective, multicenter, observational cohort study in the United Kingdom
J2  - J Neurosurg
SP  - 732
PY  - 2017
VL  - 127
SP  - 732
ER  - 
TY  - JOUR
LB  - 9.
AU  - Wada, T
AU  - Kuroda, K
AU  - Yoshida, Y
AU  - Ogasawara, K
AU  - Ogawa, A
AU  - Endo, S
TI  -  Local elevation of the anti-inflammatory interleukin-10 in the pathogenesis of chronic subdural hematoma
J2  - Neurosurg Rev
SP  - 242
PY  - 2006
VL  - 29
SP  - 242
ER  - 
TY  - JOUR
LB  - 10.
AU  - Hong, HJ
AU  - Kim, YJ
AU  - Yi, HJ
AU  - Ko, Y
AU  - Oh, SJ
AU  - Kim, JM
TI  -  Role of angiogenic growth factors and inflammatory cytokine on recurrence of chronic subdural hematoma
J2  - Surg Neurol
SP  - 161
PY  - 2009
VL  - 71
SP  - 161
ER  - 
TY  - JOUR
LB  - 11.
AU  - Stanisic, M
AU  - Aasen, AO
AU  - Pripp, AH
AU  - Lindegaard, KF
AU  - Ramm-Pettersen, J
AU  - Lyngstadaas, SP
TI  -  Local and systemic pro-inflammatory and anti-inflammatory cytokine patterns in patients with chronic subdural hematoma: a prospective study
J2  - Inflamm Res
SP  - 845
PY  - 2012
VL  - 61
SP  - 845
ER  - 
TY  - JOUR
LB  - 12.
AU  - Frati, A
AU  - Salvati, M
AU  - Mainiero, F
AU  - Ippoliti, F
AU  - Rocchi, G
AU  - Raco, A
TI  -  Inflammation markers and risk factors for recurrence in 35 patients with a posttraumatic chronic subdural hematoma: a prospective study
J2  - J Neurosurg
SP  - 24
PY  - 2004
VL  - 100
SP  - 24
ER  - 
TY  - JOUR
LB  - 13.
AU  - Suzuki, M
AU  - Endo, S
AU  - Inada, K
AU  - Kudo, A
AU  - Kitakami, A
AU  - Kuroda, K
AU  - Ogawa, A
TI  -  Inflammatory cytokines locally elevated in chronic subdural haematoma
J2  - Acta Neurochir
SP  - 51
PY  - 1998
VL  - 140
SP  - 51
ER  - 
TY  - JOUR
LB  - 14.
AU  - Sun, TF
AU  - Boet, R
AU  - Poon, WS
TI  -  Non-surgical primary treatment of chronic subdural haematoma: preliminary results of using dexamethasone
J2  - Br J Neurosurg
SP  - 327
PY  - 2005
VL  - 19
SP  - 327
ER  - 
TY  - JOUR
LB  - 15.
AU  - Delgado-López, PD
AU  - Martín-Velasco, V
AU  - Castilla-Díez, JM
AU  - Rodríguez-Salazar, A
AU  - Galacho-Harriero, AM
AU  - Fernández-Arconada, O
TI  -  Dexamethasone treatment in chronic subdural haematoma
J2  - Neurocirugia
SP  - 346
PY  - 2009
VL  - 20
SP  - 346
ER  - 
TY  - JOUR
LB  - 16.
AU  - Berghauser Pont, LM
AU  - Dirven, CM
AU  - Dippel, DW
AU  - Verweij, BH
AU  - Dammers, R
TI  -  The role of corticosteroids in the management of chronic subdural hematoma: a systematic review
J2  - Eur J Neurol
SP  - 1397
PY  - 2012
VL  - 19
SP  - 1397
ER  - 
TY  - JOUR
LB  - 17.
AU  - Chan, DYC
AU  - Sun, TFD
AU  - Poon, WS
TI  -  Steroid for chronic subdural hematoma? A prospective phase IIB pilot randomized controlled trial on the use of dexamethasone with surgical drainage for the reduction of recurrence with reoperation
J2  - Chinese Neurosurg J
SP  - 30
PY  - 2015
VL  - 1
SP  - 30
ER  - 
TY  - JOUR
LB  - 18.
AU  - Holl, DC
AU  - Volovici, V
AU  - Dirven, CMF
AU  - van Kooten, F
AU  - Miah, IP
AU  - Jellema, K
TI  -  Corticosteroid treatment compared with surgery in chronic subdural hematoma: a systematic review and meta-analysis
J2  - Acta Neurochir
SP  - 1231
PY  - 2019
VL  - 161
SP  - 1231
ER  - 
TY  - JOUR
LB  - 19.
AU  - Kawai, S
AU  - Ichikawa, Y
AU  - Homma, M
TI  -  Differences in metabolic properties among cortisol, prednisolone, and dexamethasone in liver and renal diseases: accelerated metabolism of dexamethasone in renal failure
J2  - J Clin Endocrinol Metab
SP  - 848
PY  - 1985
VL  - 60
SP  - 848
ER  - 
TY  - BOOK
LB  - 20.
AU  - Reulen, HJ
AU  - Hadjidimos, A
AU  - Hase, U
AU  - Schürmann, K
AU  - Brock, M
AU  - Reulen, HJ
AU  - Voth, D
TI  -  Steroids in the treatment of brain edema
J2  - Brain Edema/Cerebello Pontine Angle Tumors. Advances in Neurosurgery, vol 1
SP  - 92
PY  - 1973
SP  - 92
ER  - 
TY  - JOUR
LB  - 21.
AU  - Lipman, AG
TI  -  MARTINDALE: ‘Martindale – the Extra Pharmacopoeia’ (30th ed), edited by J. E. F. Reynolds
J2  - Int J Pharm Pract
SP  - 124
PY  - 1993
VL  - 2
SP  - 124
ER  - 
TY  - JOUR
LB  - 22.
AU  - Manson, SC
AU  - Brown, RE
AU  - Cerulli, A
AU  - Vidaurre, CF
TI  -  The cumulative burden of oral corticosteroid side effects and the economic implications of steroid use
J2  - Respir Med
SP  - 975
PY  - 2009
VL  - 103
SP  - 975
ER  - 
TY  - JOUR
LB  - 23.
AU  - Emich, S
AU  - Richling, B
AU  - McCoy, MR
AU  - Al-Schameri, RA
AU  - Ling, F
AU  - Sun, L
TI  -  The efficacy of dexamethasone on reduction in the reoperation rate of chronic subdural hematoma – the DRESH study: straightforward study protocol for a randomized controlled trial
J2  - Trials
SP  - 6
PY  - 2014
VL  - 15
SP  - 6
ER  - 
TY  - JOUR
LB  - 24.
AU  - Teasdale, G
AU  - Allan, D
AU  - Brennan, P
AU  - McElhinney, E
AU  - Mckinnon, L
TI  -  Forty years on: updating the Glasgow Coma Scale
J2  - Nurs Times
SP  - 12
PY  - 2014
VL  - 110
SP  - 12
ER  - 
TY  - JOUR
LB  - 25.
AU  - Bruno, A
AU  - Akinwuntan, AE
AU  - Lin, C
AU  - Close, B
AU  - Davis, K
AU  - Baute, V
TI  -  Simplified modified rankin scale questionnaire: reproducibility over the telephone and validation with quality of life
J2  - Stroke
SP  - 2276
PY  - 2011
VL  - 42
SP  - 2276
ER  - 
TY  - JOUR
LB  - 26.
AU  - Sulter, G
AU  - Steen, C
AU  - De Keyser, J
TI  -  Acute stroke trials
J2  - Stroke
SP  - 1538
PY  - 1999
SP  - 1538
ER  - 
TY  - JOUR
LB  - 27.
AU  - Janssen, MF
AU  - Pickard, AS
AU  - Golicki, D
AU  - Gudex, C
AU  - Niewada, M
AU  - Scalone, L
TI  -  Measurement properties of the EQ-5D-5L compared to the EQ-5D-3L across eight patient groups: a multi-country study
J2  - Qual Life Res
SP  - 1717
PY  - 2013
VL  - 22
SP  - 1717
ER  - 
TY  - JOUR
LB  - 28.
AU  - Chari, A
AU  - Hocking, KC
AU  - Broughton, E
AU  - Turner, C
AU  - Santarius, T
AU  - Hutchinson, PJ
AU  - Kolias, AG
TI  -  Core outcomes and common data elements in chronic subdural hematoma: a systematic review of the literature focusing on reported outcomes
J2  - J Neurotrauma
SP  - 1212
PY  - 2016
VL  - 33
SP  - 1212
ER  - 
TY  - JOUR
LB  - 29.
AU  - Herdman, M
AU  - Gudex, C
AU  - Lloyd, A
AU  - Janssen, M
AU  - Kind, P
AU  - Parkin, D
TI  -  Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L)
J2  - Qual Life Res
SP  - 1727
PY  - 2011
VL  - 20
SP  - 1727
ER  - 
TY  - JOUR
LB  - 30.
AU  - van Hout, B
AU  - Janssen, MF
AU  - Feng, YS
AU  - Kohlmann, T
AU  - Busschbach, J
AU  - Golicki, D
TI  -  Interim scoring for the EQ-5D-5L: mapping the EQ-5D-5L to EQ-5D-3L value sets
J2  - Value Health
SP  - 708
PY  - 2012
VL  - 15
SP  - 708
ER  - 
TY  - GEN
LB  - 31.
AU  - National Institute for Health and Care Excellence (NICE)
J2  - Position Statement on Use of the EQ-5D-5L Value Set for England (Updated October 2019)
PY  - 2019
ER  - 
TY  - JOUR
LB  - 32.
AU  - Allison, A
AU  - Edlmann, E
AU  - Kolias, AG
AU  - Davis-Wilkie, C
AU  - Mee, H
AU  - Thelin, EP
TI  -  Statistical analysis plan for the Dex-CSDH trial: a randomised, double-blind, placebo-controlled trial of a 2-week course of dexamethasone for adult patients with a symptomatic chronic subdural haematoma
J2  - Trials
SP  - 698
PY  - 2019
VL  - 20
SP  - 698
ER  - 
TY  - JOUR
LB  - 33.
AU  - Peugh, JL
AU  - Strotman, D
AU  - Mcgrady, M
AU  - Rausch, J
AU  - Kashikar-Zuck, S
TI  -  Beyond intent to treat (ITT): a complier average causal effect (CACE) estimation primer
J2  - J Sch Psychol
SP  - 7
PY  - 2017
VL  - 60
SP  - 7
ER  - 
TY  - JOUR
LB  - 34.
AU  - Koladjo, BF
AU  - Escolano, S
AU  - Tubert-Bitter, P
TI  -  Instrumental variable analysis in the context of dichotomous outcome and exposure with a numerical experiment in pharmacoepidemiology
J2  - BMC Med Res Methodol
SP  - 61
PY  - 2018
VL  - 18
SP  - 61
ER  - 
TY  - JOUR
LB  - 35.
AU  - Husereau, D
AU  - Drummond, M
AU  - Petrou, S
AU  - Carswell, C
AU  - Moher, D
AU  - Greenberg, D
TI  -  Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement
J2  - Cost Eff Resour Alloc
SP  - 6
PY  - 2013
VL  - 11
SP  - 6
ER  - 
TY  - GEN
LB  - 36.
AU  - National Institute for Health and Care Excellence (NICE)
J2  - Guide to the Methods of Technology Appraisal 2013. Process and Methods [PMG9]
PY  - 2013
ER  - 
TY  - BOOK
LB  - 37.
AU  - Curtis, L
AU  - Burns, A
J2  - Unit Costs of Health and Social Care 2019
PY  - 2019
ER  - 
TY  - JOUR
LB  - 38.
AU  - Ramsey, SD
AU  - Willke, RJ
AU  - Glick, H
AU  - Reed, SD
AU  - Augustovski, F
AU  - Jonsson, B
TI  -  Cost-effectiveness analysis alongside clinical trials II-An ISPOR Good Research Practices Task Force report
J2  - Value Health
SP  - 161
PY  - 2015
VL  - 18
SP  - 161
ER  - 
TY  - ELEC
LB  - 39.
AU  - NHS Digital
J2  - Prescription Cost Analysis – England, 2018 [PAS]
PY  - 2018
ER  - 
TY  - ELEC
LB  - 40.
AU  - NHS Digital
J2  - Prescription Cost Analysis – England, 2017
PY  - 2017
ER  - 
TY  - GEN
LB  - 41.
AU  - Public Health Scotland
J2  - R142X: Theatre – Direct Cost per Hour, by Specialty
PY  - 2018
ER  - 
TY  - GEN
LB  - 42.
AU  - NHS Improvement
J2  - NHS Reference Costs
PY  - 2018
ER  - 
TY  - JOUR
LB  - 43.
AU  - Turner-Stokes, L
AU  - Williams, H
AU  - Bill, A
AU  - Bassett, P
AU  - Sephton, K
TI  -  Cost-efficiency of specialist inpatient rehabilitation for working-aged adults with complex neurological disabilities: a multicentre cohort analysis of a national clinical data set
J2  - BMJ Open
SP  - e010238
PY  - 2016
VL  - 6
SP  - e010238
ER  - 
TY  - BOOK
LB  - 44.
AU  - Curtis, L
AU  - Burns, A
J2  - Unit Costs of Health and Social Care 2018
PY  - 2018
ER  - 
TY  - BOOK
LB  - 45.
AU  - Curtis, L
J2  - Unit Costs of Health and Social Care 2015
PY  - 2015
ER  - 
TY  - BOOK
LB  - 46.
AU  - Curtis, L
J2  - Unit Costs of Health and Social Care 2010
PY  - 2010
ER  - 
TY  - BOOK
LB  - 47.
AU  - Curtis, L
AU  - Burns, A
J2  - Unit Costs of Health and Social Care 2017
PY  - 2017
ER  - 
TY  - GEN
LB  - 48.
AU  - Office for National Statistics
J2  - Earnings and Hours Worked, All Employees: ASHE Table 1
PY  - 2018
ER  - 
TY  - JOUR
LB  - 49.
AU  - Hoefman, RJ
AU  - van Exel, J
AU  - Brouwer, W
TI  -  How to include informal care in economic evaluations
J2  - PharmacoEconomics
SP  - 1105
PY  - 2013
VL  - 31
SP  - 1105
ER  - 
TY  - BOOK
LB  - 50.
AU  - Drummond, M
AU  - Sculpher, M
AU  - Claxton, K
AU  - Stoddart, G
AU  - Torrance, G
J2  - Methods for the Economic Evaluation of Health Care Programmes
PY  - 2015
ER  - 
TY  - JOUR
LB  - 51.
AU  - Manca, A
AU  - Palmer, S
TI  -  Handling missing data in patient-level cost-effectiveness analysis alongside randomised clinical trials
J2  - Appl Health Econ Health Policy
SP  - 65
PY  - 2005
VL  - 4
SP  - 65
ER  - 
TY  - JOUR
LB  - 52.
AU  - Faria, R
AU  - Gomes, M
AU  - Epstein, D
AU  - White, IR
TI  -  A guide to handling missing data in cost-effectiveness analysis conducted within randomised controlled trials
J2  - PharmacoEconomics
SP  - 1157
PY  - 2014
VL  - 32
SP  - 1157
ER  - 
TY  - BOOK
LB  - 53.
AU  - Little, R
AU  - Rubin, D
J2  - Statistical Analysis with Missing Data
PY  - 2014
ER  - 
TY  - JOUR
LB  - 54.
AU  - Willan, AR
AU  - Briggs, AH
AU  - Hoch, JS
TI  -  Regression methods for covariate adjustment and subgroup analysis for non-censored cost-effectiveness data
J2  - Health Econ
SP  - 461
PY  - 2004
VL  - 13
SP  - 461
ER  - 
TY  - JOUR
LB  - 55.
AU  - Stinnett, AA
AU  - Mullahy, J
TI  -  Net health benefits: a new framework for the analysis of uncertainty in cost-effectiveness analysis
J2  - Med Decis Making
SP  - 68
PY  - 1998
VL  - 18
SP  - 68
ER  - 
TY  - JOUR
LB  - 56.
AU  - Fenwick, E
AU  - O’Brien, BJ
AU  - Briggs, A
TI  -  Cost-effectiveness acceptability curves – facts, fallacies and frequently asked questions
J2  - Health Econ
SP  - 405
PY  - 2004
VL  - 13
SP  - 405
ER  - 
TY  - JOUR
LB  - 57.
AU  - Claxton, K
TI  -  The irrelevance of inference: a decision-making approach to the stochastic evaluation of health care technologies
J2  - J Health Econ
SP  - 341
PY  - 1999
VL  - 18
SP  - 341
ER  - 
TY  - JOUR
LB  - 58.
AU  - Miah, IP
AU  - Holl, DC
AU  - Peul, WC
AU  - Walchenbach, R
AU  - Kruyt, N
AU  - de Laat, K
TI  -  Dexamethasone therapy versus surgery for chronic subdural haematoma (DECSA trial): study protocol for a randomised controlled trial
J2  - Trials
SP  - 575
PY  - 2018
VL  - 19
SP  - 575
ER  - 
TY  - JOUR
LB  - 59.
AU  - Schucht, P
AU  - Fischer, U
AU  - Fung, C
AU  - Bernasconi, C
AU  - Fichtner, J
AU  - Vulcu, S
TI  -  Follow-up computed tomography after evacuation of chronic subdural hematoma
J2  - N Engl J Med
SP  - 1186
PY  - 2019
VL  - 380
SP  - 1186
ER  -